bio transformation presentation

Upload: dhainey

Post on 30-May-2018

214 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/14/2019 Bio Transformation Presentation

    1/28

    Drug metabolism andDrug metabolism andexcretionexcretion

    ARLENE M. DIAZ M.D, F.P.S.C.E.PARLENE M. DIAZ M.D, F.P.S.C.E.PPHARMACOLOGY DEPT.PHARMACOLOGY DEPT.

    S.W.U- MHAMS.W.U- MHAM

  • 8/14/2019 Bio Transformation Presentation

    2/28

    BiotransformationBiotransformationis a process wherein a drug undergoes ais a process wherein a drug undergoes achemical change due to its interaction with anchemical change due to its interaction with anendogenous enzyme system (due to a nonenzymaticendogenous enzyme system (due to a nonenzymaticreactions) resulting in an increase of polarity of thereactions) resulting in an increase of polarity of thedrug.drug.

  • 8/14/2019 Bio Transformation Presentation

    3/28

    Why should a drug undergoesWhy should a drug undergoesBiotransformation?Biotransformation?

    1. to convert a drug to a more excretable metabolite1. to convert a drug to a more excretable metabolite

    3. to convert an active drug to an active

    metabolite

    5. to convert a drug into a more toxic

    metabolite

    2. to convert a pharmacologically activedrugto inactive metabolite

    4. to convert an inactive drug to an activemetabolite

  • 8/14/2019 Bio Transformation Presentation

    4/28

    Organs responsible for BiotransformationOrgans responsible for Biotransformation

    A.A. Liver Major DMMSLiver Major DMMS

    B. Kidney

  • 8/14/2019 Bio Transformation Presentation

    5/28

    Organs responsible for BiotransformatioOrgans responsible for Biotransformatio

    C. Lung

    D. GIT

    (intestines)

  • 8/14/2019 Bio Transformation Presentation

    6/28

    Classification of the ChemicalClassification of the Chemicalreactions of enzymaticreactions of enzymatic

    biotransformationbiotransformation

    Phase I ReactionPhase I Reaction convert the parent drug to a convert the parent drug to amore polar drug metabolite by:more polar drug metabolite by:

    Oxidation

    Hydrolysis

    Reduction

  • 8/14/2019 Bio Transformation Presentation

    7/28

    Oxidation-is the addition of oxygen orthe removal of hyrogen from the original

    compound

    -Is carried out by a group ofmonooxygenases (oxidative enzymes foundin the hepatic endoplasmic reticulum). Thismonooxygeneses are usually a large family

    of isozymes called cytochrome P450 whichactivates molecular oxygen using reducingequivalents such as Nicotinamide adeninedinucleotide phospate (NADPH).

  • 8/14/2019 Bio Transformation Presentation

    8/28

    Oxidation

    H2O

    OxidizedDrug (ROH+)

    Drug (RH)

    Oxidized

    Cytochrome P-450

    O2

    +

    e-

    Step 1

    Step 3

    FLA-PRO

    FLA-PRO

    NADP+

    NADP

    Drug-Fe3+

    Drug-Fe2+

    Step 2

    drug Fe2+-O2

    2H+

    Reduced

    Fe3

    Step 4

    5

  • 8/14/2019 Bio Transformation Presentation

    9/28

    Reduction- the removal of oxygen orthe adding of hydrogen to the original

    compound. Enzymes responsible, areusually located in the cell cytoplasm.

    Redox Recycling is a kind of reduction

    for Quinone containing drugs wherein this

    quinone containing drug is reduced by a single

    electron and is converted to an unstablesemiquinone which undergoes autooxidation

    or molecular oxygen, forming free

    radicals (superoxide which are toxic)

  • 8/14/2019 Bio Transformation Presentation

    10/28

    Redoxrecycling:

    O2

    O2

    O

    O

    O

    O

    NADPH

    FLA-PRO

    NADP+

    superoxide

    Molecularoxygen

    1 2

    Quinone

    Semi-Quinone

  • 8/14/2019 Bio Transformation Presentation

    11/28

    Phase I - Microsomal (enzymatic)

    Drug Biotransformation Reaction

    Aliphatic hydroxylation -Pentobarbital;

    Phenylbutazone

    N Hydroxylation 2 Acetylaminofluorene

    Sulfoxidation -chlorpromazine

    Epoxidation Benzo(a) pyrene; aflatoxin

    O Dealkylation Codeine

    Aromatic hydroxylation Phenytoin

    N-DealkylationDiazepam,Prazepam, Methadone

    Desulfuration Parathion

    Dehalogenation Halothane

    A. Oxidation Reaction

  • 8/14/2019 Bio Transformation Presentation

    12/28

    B. Reduction Reactions

    Nitro reduction Chloramphenicol

    Clonazepam

    Azo reduction Prontosil

    Reductive dehalogenation

    Carbon tetrachloride, DDT

    Redox recycling Doxorubicin,

    Mitomycin,Bleomycin

  • 8/14/2019 Bio Transformation Presentation

    13/28

    C. Hydrolysis- the original compound is broken

    into smaller parts. The enzyme resposible arelocated in the cytoplasm, the endoplasmic reticulumand circulating in the plasma

    Amide - Procainamide,

    Lidocaine, Indomethacin

    Ester Hydrolysis - Acetycholine,Succinylcholine, Aspirin, Procaine

    Peptide - Pro-insulin

  • 8/14/2019 Bio Transformation Presentation

    14/28

    Phase II - Conjugation RXNS

    RXN Type

    a.Glucuronidation

    b. Sulfation

    c. Acetylation

    d. Methylation

    e. Glutathione

    Enzyme

    UDP-glucuronyl

    transferases

    Sulfotransferases

    Acyl COA transferases

    Mythyl transferases

    GSH transferases

    Example

    Bilirubin, Diazepam

    Chloramphenicol

    Esterone, Andosterone

    Acetaminophen

    Isoniazide

    Sulfonamide

    Norepinephrine

    Thiouracil

    BromobenzeneEnthacrynic acid

  • 8/14/2019 Bio Transformation Presentation

    15/28

    Induction of the Drug Metabolizing Microsomal System

    How Does It Occur?

    Induction of the Drug MetabolizingMicrosomal System

    The inducer binds to the specific- receptor

    molecule in the cytoplasm of the hepatocyteforming an inducer-receptor complex.

    The receptor-inducer complex is the translocatedinto the nucleous and interact with DNA resultingto transcription of specific genes.

    The MRNA transcribed from DNASubsequently translated leading to synthesisand incorporation of new cytochrome P450 intothe membrane of the endoplasmic reticulum.

  • 8/14/2019 Bio Transformation Presentation

    16/28

    Significance of DMMS Induction

    Inactivation or diminishing effect ofthe drug(development of tolerance)

    There is an increase metabolismof other drugs takensimultaneously by the inducer.

    There is an increase metabolism ofdrugs having the samebiotransformation pathway of the

    inducer.

    E l f D th t

  • 8/14/2019 Bio Transformation Presentation

    17/28

    Example of Drugs thatEnhance drug Metabolism in

    humansInducer Drug whose metabolism is

    enhanced

    Chlorcyclizine

    Ethychlorvynol

    Glutethimide

    Griseofulvin

    Steroid hormones

    Warfarin

    Antipyrine,glutethimide, warfarin

    Warfarin

  • 8/14/2019 Bio Transformation Presentation

    18/28

    Example of Drugs that Enhance drugMetabolism in humans

    Phenobarbital

    and otherbarbiturates

    Barbiturates

    ChloramphenicolChlorpromazine

    Cortisol, coumarin

    Anticoagulants,

    Desmethylimipramine

    Digitoxin,

    Inducer Drug whose metabolism isenhanced

  • 8/14/2019 Bio Transformation Presentation

    19/28

    Doxorubicin, estradiol

    Phenylbutazone

    Phenytoin

    theophylline

    Quinine

    Testosterone

    Example of Drugs that Enhancedrug Metabolism in humans

    Inducer

    phenobarbital

    BARBITURATES

    Drug whose metabolism isenhanced

    E l f D th t

  • 8/14/2019 Bio Transformation Presentation

    20/28

    cortisol, dexamethasone,digitoxin,

    theophylline

    Example of Drugs thatEnhance drug Metabolism in

    humansDrug whose metabolism isenhanced

    Inducer

    Phenybutazone

    Phenytoin

    Rifampicin

    Aminopyrine, cortisol, digitoxin

    Coumarin, digitoxin, methadone,

    glucocorticoids, metoprolol

    Oral contraceptives, prednisone,

    propranolol, Quinidine

  • 8/14/2019 Bio Transformation Presentation

    21/28

    Drugs that inhibit metabolismof other drugs in human

    Inhibitor Drugs whosemetabolism is inhibited

    Allopurinol,

    Chloramphanicol,Isoniazid

    Antipyrine, dicumarol

    probenecid, tolbutamide,

    CimetidineChlordiazepoxide, diazepam,

    warfarin

    Dicumarol Phenytoin

    Disulfiram Antipyrine, ethanol,

    phenytoin warfarin

  • 8/14/2019 Bio Transformation Presentation

    22/28

    Drugs that inhibit metabolism ofother drugs in human

    Inhibitor Drugs whose metabolismis inhibited

    Ketoconazole Cyclosporine,astemizole,terfenadinePhenylbutazone Phenytoin, tolbutamide

    Erythromycin Amiodarone,digoxin,

    antipsychotics,theophylline

    Grapefruit juice terfenadine, calcium blockerETHANOL DIAZEPAM,

    CHLORDIAZEPOXIDE

  • 8/14/2019 Bio Transformation Presentation

    23/28

    Drugs ExertionDrugs

    Distribution

    Absorption

    Metabolism

    Biotransformation

    Liver MainOrgan

    Kidney

    Lungs

    GIT

    Excretion

    Kidney Main Organ

    Minor Routes of Excretion

    GIT Biliary/Fecal

    Mamary Milk ExcretionLungs

    Salivary - Saliva

    Sweat Glands

    Lacrimal - Tears

    Hair/ Nails/ Skin

  • 8/14/2019 Bio Transformation Presentation

    24/28

    3 Major Processes Involved in theRenal Handling of Drugs

    1.Glomerular Filtration

    3.Tubular Secretion

    2.Tubular Reabsorption

    of a drug at the glomerulus depends on themolecular size of the drugs

    usually occurs in the proximal tabules andgenerally involves organic acids such as:

    Penicillin, aspirin and diuretics

    occurs in Proximal and Distal part of the

    nephron

  • 8/14/2019 Bio Transformation Presentation

    25/28

    Factors That Will Promote

    Tubular Reabsorption

    Ionization

    Ph OfDrugs

    Lipid Solubility

  • 8/14/2019 Bio Transformation Presentation

    26/28

    Half Life (t1/2) is the time it takes forthe plasma cone or the amount of drugs in

    the body to be reduced by 50%. Volume of distribution relates theamount of drugs in the body to theconcentration of drug in the blood or

    plasma Clearance measure of the bodys

    ability to eliminate a drug

    Half Life of a drug is inversely relatedto its clearance and directly proportional

    to its volume of distribution

  • 8/14/2019 Bio Transformation Presentation

    27/28

    Clinical situations resulting in

    increased drug half life

    Diminished renal plasma flow, for ex: incardiogenic shock, heart failure or hemorrhage

    With decrease excretion renal diseases

    With addition of a second drug w/c displacesthe first drug from albumin, hence, increases

    the volume of distribution of the drug

    With decrease metabolism, for Ex. When another drug inhibits its

    biotransformation

  • 8/14/2019 Bio Transformation Presentation

    28/28

    Effect of urine Ph on renal clearance for

    drugs that undergo tubular reabsorption

    Cleared rapidly by makingurine more acidic

    Amphetamine

    Chloroquine

    Levorphanol

    Imipramine

    Mecamylamine

    Bases

    Quinine

    cleared rapidly bymaking urine alkaline

    Acetazolamide

    Nitrofurantoin

    Phenobarbital

    Probenecid

    Salicylates

    Acids

    Sulfathiazole